153 related articles for article (PubMed ID: 20923451)
1. A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma.
Teh MT; Parkinson EK; Thurlow JK; Liu F; Fortune F; Wan H
J Oral Pathol Med; 2011 Jan; 40(1):67-76. PubMed ID: 20923451
[TBL] [Abstract][Full Text] [Related]
2. The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C.
Denning MF; Guy SG; Ellerbroek SM; Norvell SM; Kowalczyk AP; Green KJ
Exp Cell Res; 1998 Feb; 239(1):50-9. PubMed ID: 9511724
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein 2 compensates for desmoglein 3 but does not control cell adhesion via regulation of p38 mitogen-activated protein kinase in keratinocytes.
Hartlieb E; Rötzer V; Radeva M; Spindler V; Waschke J
J Biol Chem; 2014 Jun; 289(24):17043-53. PubMed ID: 24782306
[TBL] [Abstract][Full Text] [Related]
4. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
5. Loss of correlation between intensities of desmoglein 2 and desmoglein 3 expression in basal cell carcinomas.
Gornowicz-Porowska J; Bowszyc-Dmochowska M; Seraszek-Jaros A; Kaczmarek E; Dmochowski M
Acta Dermatovenerol Croat; 2011; 19(3):150-5. PubMed ID: 21933638
[TBL] [Abstract][Full Text] [Related]
6. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.
Chen YJ; Chang JT; Lee L; Wang HM; Liao CT; Chiu CC; Chen PJ; Cheng AJ
Oncogene; 2007 Jan; 26(3):467-76. PubMed ID: 16878157
[TBL] [Abstract][Full Text] [Related]
7. Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins.
Schäfer S; Koch PJ; Franke WW
Exp Cell Res; 1994 Apr; 211(2):391-9. PubMed ID: 8143788
[TBL] [Abstract][Full Text] [Related]
8. Desmoglein 2 is less important than desmoglein 3 for keratinocyte cohesion.
Hartlieb E; Kempf B; Partilla M; Vigh B; Spindler V; Waschke J
PLoS One; 2013; 8(1):e53739. PubMed ID: 23326495
[TBL] [Abstract][Full Text] [Related]
9. Alterations in gene expression and activity during squamous cell carcinoma development.
Serewko MM; Popa C; Dahler AL; Smith L; Strutton GM; Coman W; Dicker AJ; Saunders NA
Cancer Res; 2002 Jul; 62(13):3759-65. PubMed ID: 12097286
[TBL] [Abstract][Full Text] [Related]
10. Discordant expression of desmoglein 2 and 3 at the mRNA and protein levels in nodular and superficial basal cell carcinoma revealed by immunohistochemistry and fluorescent in situ hybridization.
Pietkiewicz P; Gornowicz-Porowska J; Bowszyc-Dmochowska M; Jagielska J; Helak-Łapaj C; Kaczmarek E; Dmochowski M
Clin Exp Dermatol; 2014 Jul; 39(5):628-35. PubMed ID: 24934917
[TBL] [Abstract][Full Text] [Related]
11. Loss of adhesion-regulated proteinase production is correlated with invasive activity in oral squamous cell carcinoma.
Ghosh S; Munshi HG; Sen R; Linz-McGillem LA; Goldman RD; Lorch J; Green KJ; Jones JC; Stack MS
Cancer; 2002 Dec; 95(12):2524-33. PubMed ID: 12467066
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
13. Divergent routes to oral cancer.
Hunter KD; Thurlow JK; Fleming J; Drake PJ; Vass JK; Kalna G; Higham DJ; Herzyk P; Macdonald DG; Parkinson EK; Harrison PR
Cancer Res; 2006 Aug; 66(15):7405-13. PubMed ID: 16885335
[TBL] [Abstract][Full Text] [Related]
14. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
[TBL] [Abstract][Full Text] [Related]
15. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes.
Brennan D; Hu Y; Joubeh S; Choi YW; Whitaker-Menezes D; O'Brien T; Uitto J; Rodeck U; Mahoney MG
J Cell Sci; 2007 Mar; 120(Pt 5):758-71. PubMed ID: 17284515
[TBL] [Abstract][Full Text] [Related]
16. Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma.
Langlands K; Down GA; Kealey T
Cancer Res; 2000 Nov; 60(21):5929-33. PubMed ID: 11085505
[TBL] [Abstract][Full Text] [Related]
17. Expression of desmogleins 1-3 and their clinical impacts on human lung cancer.
Saaber F; Chen Y; Cui T; Yang L; Mireskandari M; Petersen I
Pathol Res Pract; 2015 Mar; 211(3):208-13. PubMed ID: 25468811
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour.
Shinohara M; Hiraki A; Ikebe T; Nakamura S; Kurahara S; Shirasuna K; Garrod DR
J Pathol; 1998 Apr; 184(4):369-81. PubMed ID: 9664902
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma.
Lim KP; Cirillo N; Hassona Y; Wei W; Thurlow JK; Cheong SC; Pitiyage G; Parkinson EK; Prime SS
J Pathol; 2011 Mar; 223(4):459-69. PubMed ID: 21294120
[TBL] [Abstract][Full Text] [Related]
20. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
